In this short video we discuss:
• Elixinol’s (EXL) three key business units, including the established U.S. operations, where it manufactures and distributes industrial hemp-based nutraceuticals, dietary supplements and skincare products
• EXL’s domestic operations, which were founded in 1999 and manufactures and distributes industrial hemp-derived products in Australia.
• The importance and direction of legislative changes in the medicinal cannabis market and EXL’s strategy to leverage a range of emerging cannabis related sectors including hemp, Cannabidiol (CBD) nutraceuticals and wellness products
Click here to view videohttps://youtu.be/vT0xe-MYSMI
To view more Executive Series interviews, visit:https://www.commsec.com.au/market-news/executive-series